You may be interested in a recent discussion we had with FDA Assistant Commissioner for Public Affairs George Strait about changes at the agency and their impact on public health, consumers, patients and the pharmaceutical and life-science industries. The two-part video podcast of our conversation can be viewed below.
How the FDA will address issues ranging from transparency, faster approvals of new medicines and devices, fostering innovation, streamlining the regulatory process and the implementation of Risk Evaluation Mitigation Strategies are top of mind to many of us in the health care field.
Eyes are focused on Commissioner Margaret Hamburg and the changes her leadership team is expected to bring to the Food and Drug Administration.
Part One | Part Two
